Medicine & Health News

Silent genetic mutations can predict the development of cancer cells

Tel Aviv University (TAU) researchers have been able to use silent mutations in cancer genomes to predict both a patient’s type of cancer and their survival probability, a finding that may well save lives in the future. The study was led by Professor Tamir Tuller and research student Tal Gutman of TAU’s Department of Biomedical… Read More

Sunlight enhances romantic passion

Sun exposure has its benefits, among them: enhancing passion in humans. Researchers in Professor Carmit Levy’s Tel Aviv University (TAU) laboratory have found that exposure to ultraviolet radiation from sunlight increases levels of romantic passion in both genders. The radiation affects the regulation of the endocrine system responsible for the release of sexual hormones in… Read More

3D printing takes on brain cancer

Tel Aviv University (TAU) researchers have 3D-printed a first-of-its-kind glioblastoma tumor that mimics a living cancer malignancy, powering new methods to improve treatment and accelerate the development of new drugs for the most lethal type of brain cancer.    Glioblastoma is notoriously fatal as it accounts for the majority of brain tumors and is highly… Read More

New warning sign for breast cancer

A team led by Tel Aviv University identified a new indicator of metastatic breast cancer, laying the groundwork for preventive treatment that could save millions of lives. Metastatic breast cancer, also known as Stage 4 breast cancer, occurs when cancer has spread, or “metastasized,” to other parts of the body. Mortality from breast cancer is… Read More

Study from TAU identifies differing levels of COVID-19 antibodies in men and women

A joint study conducted by researchers from Tel Aviv University (TAU) and the Shamir Medical Center (Asaf Harofe) indicates that the level of COVID-19 antibodies in the human blood stream differs according to age groups, gender, symptoms, and time elapsed since vaccination. The research examined the level of antibodies in over 26,000 blood samples taken… Read More

TAU discovery sheds new light on elusive workings of ALS

Researchers from Tel Aviv University (TAU) have identified a previously unknown intracellular process in amyotrophic lateral sclerosis (ALS) that may serve as a basis for the development of new treatments for the fatal neurodegenerative disease. “Our discovery provides new encouragement for developing ALS treatments,” says the study’s lead researcher, Professor Eran Perlson of the Department… Read More

New nanotech from TAU produces “healthy” electric current from the human body itself

A new nanotechnology development from an international research team led by Tel Aviv University researchers will make it possible to generate electric currents and voltage within the human body itself through the activation of various organs using mechanical force. The development involves a new and very strong biological material, similar to collagen, which is non-toxic… Read More